Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
VerImmune logo — Redirecting Immune Memory from Pathogens or Childhood Vaccin...

VerImmune

Redirecting Immune Memory from Pathogens or Childhood Vaccines to Target Cancer

Founded 2019 United States United States 13 employees Seed Total: $6.48M Biotechnology, Health Care +1

General Information

Company Name VerImmune
Founded Year 2019
Location United States United States +2
Employees 13
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Seed
Social

Get notified when VerImmune moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About VerImmune

VerImmune, founded in 2020, is a biotechnology and healthcare startup based in the United States. The company's slogan "Redirecting Immune Memory from Pathogens or Childhood Vaccines to Target Cancer" encapsulates its mission to advance Anti-tumor Immune Redirection (AIR), a breakthrough therapy that redirects pre-existing immune memory from childhood vaccination or infection to fight cancer. VerImmune recently secured a significant milestone with a $3.13M Seed Round investment from prominent investors including Gaingels, Mana Ventures, Proxima Ventures Ltd, and Fosun Pharma on 20 September 2023. This injection of capital is expected to fuel the company's efforts to revolutionize cancer treatment through innovative immunotherapies.

Taxonomy: Immuno-Oncology, Cancer Therapy, Anti-Tumor Immune Redirection, AIR-ViPs, Immune Memory Redirection, Tumor-Specific, Virus-Inspired Platform, Baltimore, Maryland, Childhood Vaccination, Infection, Cancer Treatment, Immune System, Innovative Therapy

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 4
Investor Investor
•••• •••• 		20 Sep 2023
Seed Round •••••• 6
Investor Investor Investor Investor Investor
•••• •••• 		27 Jul 2022
Grant •••••• - 06 May 2020

VerImmune Alternatives & Competitors

VerImmune vs
ImmunoGenesis, Inc.
ImmunoGenesis, Inc. United States

Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mechanisms of...

Series Unknown
14 employees
Biotechnology, Health Care
Compare VerImmune vs ImmunoGenesis, Inc.
VerImmune vs
MACROPHAGE PHARMA LIMITED
MACROPHAGE PHARMA LIMITED

Empowering the immune system to combat cancer with precision-targeted therapies

Series A
Biotechnology, Pharmaceutical
VerImmune vs
Kaio Therapy, LLC
Kaio Therapy, LLC

Headquartered in Raleigh, NC, Kaio Therapy, LLC is focused on the development of novel active immuno...

Series Unknown
2 employees
Health Care, Health and Wellness

FAQ About VerImmune

Redirecting Immune Memory from Pathogens or Childhood Vaccines to Target Cancer
VerImmune was founded in 2019.
VerImmune is headquartered in United States.
VerImmune operates in the following industries: Biotechnology, Health Care, Health and Wellness.
VerImmune has approximately 13 employees.
VerImmune has completed 3 funding rounds, raising a total of $6.48M. The latest funding stage is Seed.
Top alternatives and competitors to VerImmune include ImmunoGenesis, Inc., MACROPHAGE PHARMA LIMITED, Kaio Therapy, LLC, Umoja Biopharma, Inceptor Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
VerImmune and ImmunoGenesis, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors VerImmune and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy